Publication | Closed Access

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

Innovative TherapyOncologyMalignant DiseaseCancer ManagementPhase Ii StudyCancer TreatmentMedicineRadiation OncologyCancer Research